Dr. Michael Reynard, MD

NPI: 1851478481
Total Payments
$620.95
2019 Payments
$56.69
Companies
5
Transactions
18
Medicare Patients
151
Medicare Billing
$9,086

Payment Breakdown by Category

Food & Beverage$428.97 (69.1%)
Other$191.98 (30.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $428.97 17 69.1%
Entertainment $191.98 1 30.9%

Top Paying Companies

Company Total Records Latest Year
Optos, Inc. $191.98 1 $0 (2017)
Shire North American Group Inc $165.43 2 $0 (2018)
Novartis Pharmaceuticals Corporation $139.69 9 $0 (2018)
Allergan Inc. $102.50 5 $0 (2019)
Sun Pharmaceutical Industries Inc. $21.35 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2019 $56.69 3 Allergan Inc. ($35.34)
2018 $205.56 4 Shire North American Group Inc ($144.17)
2017 $358.70 11 Optos, Inc. ($191.98)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/08/2019 Allergan Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $13.22 General
Category: OPHTHALMOLOGY
02/22/2019 Allergan Inc. RESTASIS (Drug) Food and Beverage In-kind items and services $22.12 General
Category: DRY EYE
01/18/2019 Sun Pharmaceutical Industries Inc. XELPROS (Drug) Food and Beverage Cash or cash equivalent $21.35 General
Category: Ophthalmology
11/08/2018 Shire North American Group Inc XIIDRA (Drug) Food and Beverage In-kind items and services $144.17 General
Category: OPTHALMICS
10/19/2018 Allergan Inc. Food and Beverage In-kind items and services $25.00 General
05/03/2018 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $16.66 General
Category: OPHTHALMOLOGY
02/08/2018 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $19.73 General
Category: OPHTHALMOLOGY
12/18/2017 Novartis Pharmaceuticals Corporation PAZEO (Drug) Food and Beverage In-kind items and services $15.04 General
Category: OPHTHALMOLOGY
11/30/2017 Novartis Pharmaceuticals Corporation SIMBRINZA (Biological) Food and Beverage In-kind items and services $18.18 General
Category: OPHTHALMOLOGY
11/10/2017 Allergan Inc. RESTASIS (Drug) Food and Beverage In-kind items and services $18.75 General
Category: DRY EYE
11/03/2017 Shire North American Group Inc XIIDRA (Drug) Food and Beverage In-kind items and services $21.26 General
Category: OPTHALMICS
08/18/2017 Allergan Inc. RESTASIS (Drug) Food and Beverage In-kind items and services $23.41 General
Category: DRY EYE
08/09/2017 Novartis Pharmaceuticals Corporation SIMBRINZA (Biological) Food and Beverage In-kind items and services $16.21 General
Category: OPHTHALMOLOGY
04/11/2017 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $13.20 General
Category: OPHTHALMOLOGY
03/08/2017 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $22.29 General
Category: OPHTHALMOLOGY
02/28/2017 Optos, Inc. California (Device), Daytona Entertainment Cash or cash equivalent $191.98 General
Category: OPHTHALMOLOGY
02/14/2017 Novartis Pharmaceuticals Corporation PAZEO (Drug), SIMBRINZA Food and Beverage In-kind items and services $11.76 General
Category: OPHTHALMOLOGY
01/30/2017 Novartis Pharmaceuticals Corporation PAZEO (Drug), SIMBRINZA Food and Beverage In-kind items and services $6.62 General
Category: OPHTHALMOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 5 151 159 $25,895 $9,086
Total Patients
151
Total Services
159
Medicare Billing
$9,086
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 48 55 $10,175 $4,888 48.0%
92083 Measurement of field of vision during daylight conditions Office 2020 33 34 $5,100 $1,895 37.2%
92250 Photography of the retina Office 2020 36 36 $4,500 $1,217 27.1%
92134 Diagnostic imaging of retina Office 2020 21 21 $3,780 $671.69 17.8%
92133 Diagnostic imaging of optic nerve of eye Office 2020 13 13 $2,340 $413.43 17.7%

About Dr. Michael Reynard, MD

Dr. Michael Reynard, MD is a Ophthalmology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851478481.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Reynard, MD has received a total of $620.95 in payments from pharmaceutical and medical device companies, with $56.69 received in 2019. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($428.97).

As a Medicare-enrolled provider, Reynard has provided services to 151 Medicare beneficiaries, totaling 159 services with total Medicare billing of $9,086. Data is available for 1 year (2020–2020), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Santa Monica, CA
  • Active Since 11/01/2006
  • Last Updated 07/29/2008
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1851478481

Products in Payments

  • California (Device) $191.98
  • XIIDRA (Drug) $165.43
  • TRAVATAN Z (Drug) $71.88
  • RESTASIS (Drug) $64.28
  • SIMBRINZA (Biological) $34.39
  • PAZEO (Drug) $33.42
  • XELPROS (Drug) $21.35
  • LUMIGAN (Drug) $13.22

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Santa Monica